IDEXX Laboratories Introduces the IDEXX VetLab® Station Laboratory Information Management System (LIMS) [Trade]
Diagnostic data integration enables veterinarians to increase level of patient care

Westbrook, Maine, January 17, 2007—IDEXX Laboratories, Inc. (NASDAQ:IDXX), continues its commitment to innovation in veterinary medicine with the introduction of the IDEXX VetLab® Station Laboratory Information Management System (LIMS). The new computer and touch screen offer an unprecedented level of information management for customers of the IDEXX VetLab® Suite of in-house analyzers. The IDEXX VetLab Station was shipped with all LaserCyte® analyzers ordered in North America for most of 2006 but is now available for sale as a stand-alone system. This enables the entire IDEXX VetLab customer base to evolve their in-house reference laboratory capabilities, whatever set of instruments they currently operate.

The IDEXX VetLab Station LIMS integrates data generated by IDEXX in-house diagnostic instruments, allowing veterinarians to care for patients on a higher level. With virtually unlimited data storage for patient records and results, the IDEXX VetLab Station gives veterinary professionals more information on each patient at the point of care—when they need it most. Featuring a new, more powerful computer and a larger 10.4-inch touch screen, along with parameter-trending capabilities, interpretive summaries, and on-screen training guides, the IDEXX VetLab Station provides unparalleled analytical, reporting and medical reference capability.

In addition, practices will benefit from time- and labor-saving features, including the ability to run multiple IDEXX VetLab instruments from a single interface, auto-entry filling of patient and client information for reduced data entry, and easy access to integrated reports.

The IDEXX VetLab Station can serve as the primary user interface for the complete suite of IDEXX VetLab instruments—the LaserCyte® Hematology Analyzer, the VetTest® Chemistry Analyzer, the SNAP® Reader, the VetStat® Electrolyte and Blood Gas Analyzer, the VetLyte® Electrolyte Analyzer, and the IDEXX VetLab® UA™ Analyzer—consolidating and managing all of the data generated, and providing a comprehensive diagnostic information solution unique in the veterinary-practice setting. It also consolidates and manages the diagnostic data generated by IDEXX VetLab instruments in an integrated system (for example, multiple VetTest analyzers).

“The enhanced and highly flexible graphical trending capability adds an entirely new dimension to historical patient laboratory data management, bringing medically relevant developments to the attention of the veterinarian, technician and, if desired, to the client,” said Michael Williams, Corporate Vice President and General Manager of the IDEXX VetLab business unit. “The IDEXX VetLab Station’s capability will continue to grow in 2007 and beyond as we provide additional enhancements through future software releases.”

The IDEXX VetLab Station also benefits practices using the Cornerstone® Practice Management System by enabling them to upload information simply and seamlessly into patient medical records and invoices. As a result, veterinary professionals enjoy improved case management at the point of care and can focus on providing enhanced patient care and client service.

For more information or to place an order, practitioners can contact their authorized IDEXX distributor representative, call IDEXX at 1-800-355-2896 or visit www.idexx.com/vetlabstation.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice-management systems, and therapeutics. Our products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Westbrook, Maine, IDEXX Laboratories employs more than 3,500 people and offers products to customers in over 100 countries.

Note Regarding Forward-Looking Statements
This press release contains statements about the Company’s business prospects that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management’s expectations. Factors that could cause or contribute to such differences include the following: the Company’s ability to develop, manufacture, introduce and market new products and enhancements to existing products; the effectiveness of the Company’s sales and marketing activities; the Company’s ability to develop, license or obtain rights to new technologies; the Company’s ability to identify acquisition opportunities, complete acquisitions and integrate acquired businesses; the impact of competition and technological change on the markets for the Company’s products; the effect of government regulation on the Company’s business, including government decisions about whether and when to approve the Company’s products and decisions regarding labeling, manufacturing and marketing products; the impact of distributor purchasing decisions on sales of our products that are sold through distribution; changes or trends in veterinary medicine that affect the rate of use of the Company’s products and services by veterinarians; the Company’s ability to obtain patent and other intellectual property protection for its products, successfully enforce its intellectual property rights and defend itself against third party claims against the Company; disruptions, shortages or pricing changes that affect the Company’s purchases of products and materials from third parties, including from sole source suppliers; the effects of government regulatory decisions, customer demand, pricing and other factors on the realizability of the Company’s inventories; the Company’s ability to manufacture complex biologic products; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the loss of key employees. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2005 (1.5 MB), and on the Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 (520 KB), in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations."

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe^® Reader^® software.